| Name | Walgreens #3087 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 5625 E Thomas Rd, Phoenix, Arizona 85018 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (480) 949-0302 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A single-center study found that percutaneous coronary intervention (PCI) procedures performed during the middle of the night do not adversely affect the safety and effectiveness of procedures performed the next day by the same operator.
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother's gut are passed on to the baby and stimulate the baby's immune responses.
ThromboGenics NV and co-development partner BioInvent International announce today that they have completed the enrolment of a 632-patient Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism (VTE) after total hip surgery. The trial has recruited patients from 36 centers across Europe.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
› Verified 5 days ago
| NPI Number | 1275548505 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #03087 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5625 E Thomas Rd, Phoenix, AZ 85018 |
| Phone Number | 480-949-0302 |
News Archive
A single-center study found that percutaneous coronary intervention (PCI) procedures performed during the middle of the night do not adversely affect the safety and effectiveness of procedures performed the next day by the same operator.
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother's gut are passed on to the baby and stimulate the baby's immune responses.
ThromboGenics NV and co-development partner BioInvent International announce today that they have completed the enrolment of a 632-patient Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism (VTE) after total hip surgery. The trial has recruited patients from 36 centers across Europe.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
› Verified 5 days ago
News Archive
A single-center study found that percutaneous coronary intervention (PCI) procedures performed during the middle of the night do not adversely affect the safety and effectiveness of procedures performed the next day by the same operator.
YM BioSciences Inc., announced today that it has raised approximately US$3.2 million through a non-brokered private placement of 2,500,000 common shares to be issued at US$1.27. The sale price is at no discount to the closing price of the shares on the NYSE Amex on June 1, 2010.
Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother's gut are passed on to the baby and stimulate the baby's immune responses.
ThromboGenics NV and co-development partner BioInvent International announce today that they have completed the enrolment of a 632-patient Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism (VTE) after total hip surgery. The trial has recruited patients from 36 centers across Europe.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
› Verified 5 days ago
Cvs Pharmacy #03129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 E Mcdowell Rd, Phoenix, Arizona 85006 Phone: (602) 258-7051 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4601e. Hilton Ave, Phoenix, Arizona 85034 Phone: (480) 446-9010 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4602 E. Hammond Lane, Phoenix, Arizona 85034 Phone: (480) 993-2097 | |
Cvs Pharmacy 03625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8245 W Thomas Rd, Phoenix, Arizona 85033 Phone: (623) 849-2439 | |
Northland Aac Type: Medicare Supplier Location: 34406 North 27th Drive, Phoenix, Arizona 85085 Phone: (877) 893-5305 |